Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
November 06, 2025
Not intended for U.S. and UK Media – Late-Breaking data from FINE-ONE Phase III study presented at ASN Kidney Week 2025
Finerenone showed statistically significant reduction of UACR in adults with chronic kidney disease associated with type 1 diabetes
October 24, 2025
Not intended for U.S. and UK Media
Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
